We confirmed that this archetypal gain of function rearrangement resulted in elevated IRF8 expression in primary DLBCL, which in turn conferred a survival benefit to DLBCL cell line models, a finding validated by others (50). Here, IRF8 is linked to diffuse large B-cell lymphoma.